当前梅毒性葡萄膜炎的眼科实践模式
国际眼葡萄膜炎专科研究组于2017年7月成立,由35个国家103名成员完成25项问卷,调查梅毒性葡萄膜炎的病例量、临床表现、检查使用与解读、治疗及不良预后指标。成员平均管理6.1例梅毒性葡萄膜炎患者,葡萄膜炎年门诊量平均707例(占0.9%),53.2%报告过去十年病例数增加。所有成员使用血清学检测诊断,97.0%常规筛查HIV合并感染,90.2%开具脑脊液分析,92.7%以葡萄膜炎加VDRL或FTA-ABS提示神经梅毒。
要点
- 所有成员使用血清学检测诊断梅毒性葡萄膜炎,97.0%常规检查HIV合并感染。
- 90.2%成员开具脑脊液分析,92.7%以葡萄膜炎加VDRL或FTA-ABS提示神经梅毒。
- 预测不良结局的特征包括视神经病变(86.3%)和初始误诊(63.7%)。
核心结论
- 该国际眼葡萄膜炎专科研究组的综合报告提供了当前梅毒性葡萄膜炎的管理方法。
研究设计与样本
- 国际眼葡萄膜炎专科研究组于2017年7月成立,35个国家103名成员完成25项问卷,聚焦病例量、临床表现、检查使用与解读、治疗及不良预后临床指标。
主要发现
- 成员平均管理6.1例梅毒性葡萄膜炎患者,所在诊所葡萄膜炎年病例数平均707例(占0.9%),53.2%报告过去十年病例数增加。
- 40.2%成员报告患者于二期梅毒时就诊,葡萄膜炎通常为后葡萄膜炎(60.8%)或全葡萄膜炎(22.5%),并发症包括视神经病变、黄斑水肿和后粘连。
- 所有成员使用血清学检测(同时或序贯检测算法)诊断梅毒性葡萄膜炎,97.0%常规检查HIV合并感染。
- 90.2%成员开具脑脊液分析,92.7%以葡萄膜炎加VDRL或FTA-ABS提示神经梅毒,患者常与感染科医生共同管理,接受青霉素治疗至少10-14天加皮质类固醇。
- 预测不良结局的特征包括视神经病变(86.3%)和初始误诊(63.7%),延迟诊断的原因常与执业者相关,82.5%成员对管理的每例葡萄膜炎患者检测梅毒。
关键数值与推荐
- 所有成员使用血清学检测(同时或序贯检测算法)诊断梅毒性葡萄膜炎,97.0%常规检查HIV合并感染。
- 90.2%成员开具脑脊液分析,92.7%以葡萄膜炎加VDRL或FTA-ABS提示神经梅毒。
- 患者接受青霉素治疗至少10-14天加皮质类固醇。
- 预测不良结局的特征包括视神经病变(86.3%)和初始误诊(63.7%)。
临床怎么用
- 成员使用血清学检测诊断梅毒性葡萄膜炎,97.0%常规检查HIV合并感染,90.2%开具脑脊液分析,92.7%以葡萄膜炎加VDRL或FTA-ABS提示神经梅毒。
- 患者常与感染科医生共同管理,接受青霉素治疗至少10-14天加皮质类固醇。
- 82.5%成员对管理的每例葡萄膜炎患者检测梅毒。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Syphilitic uveitis is re-emerging alongside the systemic infection. In July 2017, an international group of uveitis-specialised ophthalmologists formed the International Ocular Syphilis Study Group to define current practice patterns. METHODS: 103 Study Group members based in 35 countries completed a 25-item questionnaire focused on case load, clinical presentations, use and interpretation of investigations, treatment and clinical indicators of poor prognosis. RESULTS: Members managed a mean of 6.1 patients with syphilitic uveitis in clinics that averaged 707 annual cases of uveitis (0.9%); 53.2% reported increasing numbers over the past decade. Patients presented to more members (40.2%) during secondary syphilis. Uveitis was usually posterior (60.8%) or pan (22.5%); complications included optic neuropathy, macular oedema and posterior synechiae. All members diagnosed syphilitic uveitis using serological tests (simultaneous or sequential testing algorithms), and 97.0% routinely checked for HIV co-infection. Cerebrospinal fluid (CSF) analysis was ordered by 90.2% of members, and 92.7% took uveitis plus Venereal Disease Research Laboratory test (VDRL) or fluorescent treponemal antibody absorption test (FTA-ABS) to indicate neurosyphilis. Patients were commonly co-managed with infectious disease physicians, and treated with penicillin for at least 10-14 days, plus corticosteroid. Features predicting poor outcome included optic neuropathy (86.3%) and initial misdiagnosis (63.7%). Reasons for delayed diagnosis were often practitioner-related. 82.5% of members tested every patient they managed with uveitis for syphilis. CONCLUSION: This comprehensive report by an international group of uveitis-specialised ophthalmologists provides a current approach for the management of syphilitic uveitis.
引用
- Oliver GF, Stathis RM, Furtado JM, et al. Current ophthalmology practice patterns for syphilitic uveitis. Br J Ophthalmol. 2019. PMID: 31021330. doi:10.1136/bjophthalmol-2018-313207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。